Amaryl (glimepiride)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Amaryl (glimepiride), covering 2016-11-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction. [Phase 3]